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ElasticityThis paper reports dynamic surface tension experiments of a lung surfactant preparation, BLES, for a wide range
of concentrations, compression ratios and compression rates. These experiments were performed using Axisym-
metric Drop Shape Analysis–Constrained Sessile Drop (ADSA–CSD). Themain purpose of the paper is to interpret
the results in terms of physical parameters using the recently developed Compression–RelaxationModel (CRM).
In the past, only the minimum surface tension was used generally for the characterization of lung surfactant
ﬁlms; however, this minimum value is not a physical parameter and depends on the compression protocol.
CRM is based on the assumption that the dynamic surface tension response is governed by surface elasticities,
adsorption and desorption of components of the lung surfactant. The ability of CRM to ﬁt the surface tension
response closely for awide variety of parameters (compression ratio, compression rate and surfactant concentra-
tion) and produce sensible values for the elastic and kinetic parameters supports the validity of CRM.
© 2011 Elsevier B.V. All rights reserved.1. Introduction
Pulmonary surfactants are mixtures of lipids and proteins suspended
as vesicles or other aggregates in the alveolar ﬂuid. These lipids and
proteins can spread to form a monolayer or possibly multilayers at the
alveolar liquid–air interface. The key property of lung surfactants is their
dynamic surface tension response to ﬁlm compression and expansion.
The surfactant at the interface modulates the surface tension of the
lung, lowering the normal air–water surface tension of approximately
70 mJ/m2 to extremely low values below 5mJ/m2 [1].
Respiratory distress syndrome (RDS) is a clinical condition deﬁned by
the onset of poor blood oxygenation due to lung injury, and lack or
malfunction of lung surfactant [1]. RDS is typically classiﬁed into neonatal
RDS (nRDS) and acute RDS (ARDS) [1,2]. Exogenous surfactant replace-
ment therapy, in which either synthetic or modiﬁed natural pulmonary
surfactant (extracted from bovine or porcine sources) is delivered into
the patients' lungs, has been established as a standard therapeutic inter-
vention for patients with nRDS [3]. Surfactant therapy has shown limited
therapeutic effect on ARDS patients [4–7].
In these therapies, high concentrations of the exogenous surfactant
are commonly used to reach an effective dose, i.e. the surfactant dose
to recover the mechanical properties of the lungs. The dose is usually
in the range of 8 mg/ml [1,8,9]. Some other formulations, e.g. bovine+1 416 978 7753.
umann).
rights reserved.lipid extracted surfactant (BLES) preparations, are used in surfactant
replacement therapy with larger doses of 27 mg/ml [10].
On the other hand, there is still a lack of in vitro studies for these
high concentrations, partly due to limitations of methodologies used.
For these studies, the maximum surfactant concentration is usually
restricted to no more than 3 mg/ml. This restriction arises from optical
limitations since surfactant suspensions become murky and eventually
opaque at increased concentrations.
Although there is promising evidence for surfactant therapy in ARDS,
the effectiveness of high doses of commercial surfactant preparations has
been inconsistent in clinical trials [11–13,7,14,15]. However, surfactant
concentration is only one strategy to address the problem.High frequency
low tidal volume ventilation, henceforth simply referred to as high fre-
quency ventilation (HFV) has been shown to reduce, even if marginally,
the mortality of ARDS [12,16–20].
Desirable features of surface tension methodologies include accurate
measurements at near zero surface tensions (requiring absence of ﬁlm
leakage) under dynamic conditions. It is necessary to pre-humidify the
air at body temperature, to be consistent with physiological conditions
[10,21,22]. To simulate normal breathing, cycling frequencies of 0.1–
0.5 Hz and a reduction in surface area near 20% are necessary [23,2,1].
However, for high frequency ventilation it is necessary to produce cycling
frequencies higher than 1 Hz [24]. Furthermore, it is important to note
that turbid concentrated suspensions are used in clinical practice [1,8].
To evaluate the effect of gases, aerosols, inhibitors, surfactant additives,
and to deposit mixed lipid ﬁlms it is useful to gain access to the air-
water interface from the air and from the aqueous phase. The constrained
sessile drop (CSD) conﬁguration in conjunction with Axisymmetric Drop
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[25–27]. Other methodologies do not necessarily allow the straightfor-
ward changes in experimental parameters. For example, Langmuir–
Wilhelmy balances do not allow for compression at high frequencies
because of the formations of waves on the surface [23,28–30].
The captive bubble (CB) is noteworthy in that it avoids all possible
pathways for ﬁlm leakage, but it has been shown that it is not suitable
for concentrated turbid suspensions (concentrations higher than
3 mg/ml) [2,31,32,33]. However, recent experiments use sub-phase
spreading of highly concentrated suspensions near the interface
[Schurch, 2010].
In the ADSA–CSD setup, a sessile drop is formed on top of a small ﬂat
pedestal with a circular sharp knife edge preventing uncontrolled
spreading and hence ﬁlm leakage [25–27]. ADSA–CSD is used to
perform dynamic cycling by successive compression/expansion of the
drop via programmed cycling of the drop volume. This is normally
done through several cycles (normally 20) with prescribed periodicity
and compression ratio (percentage of surface area reduction). In such
experiments, a large amount of data is collected including the surface
tension as a function of time as well as the change of the drop surface
area and volume. Such results can provide valuable information about
various properties of the ﬁlm.
To assess the performance of surfactant preparations subject to
dynamic compression/expansion, typically only the minimum surface
tension at the end of compression is reported. While the minimum
surface tension is useful for a preliminary assessment, it has to be
realized that it is not a thermodynamic or other physical property
as it depends on the method of compression [34]. Increasing the
extent of compression or the speed of compression may signiﬁcantly
change the value of the minimum surface tension observed [10]. In
fact, this makes the comparison of different literature values difﬁcult
in the case of different compression protocols. Therefore, it is neces-
sary to concentrate on the properties of the ﬁlm itself such as its elas-
ticity, its formation (adsorption) and its stability (or relaxation
tendency) as proposed in the literature [10,35] in addition, if not in
place of the minimum surface tension.
Recently, a new approach to evaluate the quality of lung surfactant
preparations beyond the γmin value as the only quantitative characteristic
has been developed [36]. This approach, called Compression–Relaxation
Model (CRM), calculates the ﬁlm properties independent of the compres-
sion protocol used.
Brieﬂy, there are four obvious physical properties considered in
this model: the elasticities of the ﬁlm upon ﬁlm compression and
ﬁlm expansion, an effective adsorption coefﬁcient and an effective
desorption coefﬁcient. The elastic effects are quantiﬁed by standard
surface thermodynamic deﬁnitions and the kinetic effects by stan-
dard ﬁrst order kinetic equations. The combination of these four
equations represents the Compression–Relaxation Model (CRM).Fig. 1. A schematic diagram of the Axisymmetric Drop Shape AnalyThe best ﬁt of CRM to experimental dynamic surface tension data is
sought by multi-variable optimization of the four elastic and kinetic
constants and thus determines these four constants. A special feature
of the model is its ability to account for the surface tension changes
due to simultaneous changes of more than one of these parameters,
e.g. elasticity of compression and desorption, at the same time.
Elasticity of the surfactant ﬁlm gives an indication of how much
area compression is needed to reduce the surface tension; in other
words, higher elasticity indicates that less work is needed for breath-
ing. Adsorption and relaxation indicate how fast the surfactant ﬁlms
are formed and how stable they are.
The dynamic behavior of lung surfactants plays an important role in
the performance of these formulations. For example, the group of Hall
has proposed a “super-compression" model [37] to explain the fact
that fast compressions produce better dynamic surface tension
response than slow compressions. CRM can be used as a tool to quantify
these and other dynamic effects. Examples are the adsorption dynamics
that was discussed previously [34,38] but has not been quantiﬁed in a
systematic manner to compare various surfactant preparations, or the
effect of additives and surfactant inhibitors.
In this paper, ADSA–CSD is used to measure the dynamic surface
tension of a lung surfactant preparation, BLES, at concentrations, com-
pression ratios and compression rates relevant to current exogenous
surfactant therapies. The results are analyzed using CRM to evaluate
the effect of surfactant concentration, compression ratio and compres-
sion rate on the surface activity and dynamic properties (elasticity,
adsorption and relaxation) of BLES preparations. Results show that
CRM is generally sensitive to all the parameters, i.e., elasticity, adsorp-
tion and relaxation, at any concentration at physiological conditions of
20% compression and 3 s per cycle. The model is also very sensitive to
all the parameters at any concentration at low compression ratios and
high frequency cycling. These latter conditions are relevant to the
clinical practice of high frequency ventilation.
It will be shown that CRM has the ability to ﬁt the surface tension
response closely for a wide variety of parameters (compression ratio,
compression rate and surfactant concentration) and produce sensible
values for the elastic and kinetic parameters.
The key conclusion is that the four properties above are thedeterminant
quantities for these systems.
2. Materials and experimental methods
2.1. Materials
The lung surfactant used, Bovine Lipid Extract Surfactant (BLES),
was provided by BLES Biochemicals Inc. (London, Ontario, Canada)
at a concentration of 27 mg/ml and was used without further treat-
ment. BLES was divided into 1 ml glass vials in Ar atmosphere andsis–Constrained Sessile Drop (ADSA–CSD) experimental setup.
Fig. 2. The change of surface tension and surface area with time of 1 cycle for 2.0 mg/ml
BLES at wet conditions (100% R.H.), 37 °C, and 20% compression ratio with a periodicity
of 3 s per cycle.
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at 37.5 °C water bath for 1 h before diluting it to the required concen-
tration (2, 8, 15, or 27 mg/ml) in a salt solution of 0.6% NaCl and
1.5 mM CaCl2. The pH value of the diluted BLES preparations ranged
from 5 to 6.
2.2. Experimental procedure
The details of the design and operation of the surface tension tech-
nique, ADSA–CSD, were described elsewhere [25,34,10]. A schematic
diagram of the ADSA–CSD setup is shown in Fig. 1. During the experi-
ment, the setup is enclosed in an environmental control chamber that
facilitates the control of gas composition and temperature. The
humidity inside the chamber was kept constant at 100% relative
humidity at 37 °C. The humid air is generated by ﬁlling the humidity
control reservoir with distilled water one hour before the experiment
to ensure that the chamber becomes saturated with water vapor, i.e.
the relative humidity (RH) is ~100%.
A stepping motor (controller 18705/6, Oriel Instruments, Stratford, CT)
was used to facilitate the ﬂuid volume injection/withdrawal and the
compression/expansion during the dynamic cycling part of the experiment.
A CCD camera (model 4815-5000, Cohu Corp., Poway, CA) mounted on a
horizontal microscope (type 400076, Wild Heerburgg, Switzerland) was
used to acquire images throughout the experiment at a rate of 20 images
per second for cycling speeds of 3 or 9 s per cycle and at a rate of 30 images
per second for a cycling speed of 1 s per cycle. The images were digitized
using a digital video frame grabber (Snapper-8, Active Silicon Ltd., Iver,
UK) and stored in a workstation (SunBlade 1500, Sun Microsystems,
Santa Clara, CA) for further analysis by ADSA (Axisymmetric Drop
Shape Analysis). The system temperature is thermostatically
maintained at 37±0.2 °C by a water bath (Model RTE-111, Neslab
Instruments Inc., Portsmouth, NH). The entire experimental setup,
except the computer and water bath, is mounted on a vibration-free
table (Technical Manufacturing Corp., Peabody, MA).
The experimental procedure is as follows: First, the sessile drop was
quickly formed (within 0.5 s) on the pedestal. The drop is then left undis-
turbed to allow adsorption of the lung surfactant ﬁlm. The surface tension
is tracked until the ﬁlm reaches the equilibrium surface tension (within
180 s for all cases). Thereafter, dynamic cycling is performed by succes-
sive compression/expansion of the drop. This is normally done through
20 cycles with the required periodicity (1, 3, or 9 per cycle) and the
required compression ratio (percentage of surface area reduction) of
10%, 20%, or 30%. During every experimental run, images are acquired,
stored and later analyzed with ADSA.
ADSA is a technique for measuring surface tension by matching an
extracted drop proﬁle to a theoretical one. Other outputs of ADSA are
drop surface area, drop volume and radius of curvature at the drop
apex [39–41].
All experiments were reproduced at least in triplicate. A typical
experimental result for 2.0 mg/ml BLES at 100% relative humidity,
20% compression, 3 s per cycle and 37 °C is shown in Fig. 2 showing
an example of ADSA outputs as a function of cycling time. It can be
seen that cycles repeat very well.
2.3. CRM calculations
Using the change of surface tension and areawith timeduring dynam-
ic cycling, dynamic parameters are calculated using a compression–
relaxation model (CRM). This model was introduced and described
previously [36]. Brieﬂy, in this model, there are four factors that affect
the response of the dynamic surface tension: adsorption or spreading,
desorption or relaxation, elasticity during compression and elasticity
during expansion.
In CRM, the adsorption and relaxation rates are assumed to
depend on the difference between the instantaneous surface tension
and the equilibrium value, while the elasticity for both compressionand expansion is assumed to depend on rate of change of the surface
area of the interface. The main feature of CRM is the ability to account
for the surface tension changes due to simultaneous changes of these
parameters. This is different from other models that account for surface
tension changes in different regions of a speciﬁc dominating parameter,
but not allowing the various effects to occur simultaneously.
Allowing the surface tension to change due to simultaneous effects of
relaxation/adsorption and elasticity, CRM is described by the following set
of equations [36]:
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Desirable dynamic properties of a good lung surfactant prepara-
tion are: fast adsorption rate (high ka), slow relaxation rate (low kr),
and high elasticity of compression and expansion (high c and e). It
should be noted that the rate constants are comparable only for the
same compression rate.
Following convention [42,43], the elasticity used here is deﬁned
as:
 ¼ dπ
d ln A

 ¼ d γo−γð ÞdA=A

 ð2Þ
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Fig. 3. Theminimum surface tension, γmin, measured for four different concentrations of
BLES (2, 8, 15, 27 mg/ml) at different compression ratios (10%, 20%, 30%) and different
cycling conditions (1, 3, 9 s/cycle). The error bars indicate the standard deviation
between runs repeated under the same conditions.
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the interface. For a two-dimensional interface, the stress is the surface
pressure and the strain is the change of surface area per unit area.
This corresponds to the bulk modulus in three dimensions.
The compression/relaxation model (CRM), as summarized in
Eq. (3), is able to predict the surface tension response of a surfactant
preparation, for given dynamic parameters. An initial value problem
solver for ordinary differential equation is used for the numerical
integration assuming an a priori knowledge of the above mentioned
four dynamic parameters, namely adsorption coefﬁcient (ka), desorp-
tion coefﬁcient (kr), elasticity of compression ( c), and elasticity of
expansion ( e). Conversely, for a given experimental condition, the
values of these four parameters are optimized so that the calculated
surface tension response ﬁts best that of the experimentally mea-
sured surface tension response.
Details of the numericalmethods used to obtain these four parameters
for any experimental result were presented elsewhere [36]. Brieﬂy, an
initial guess procedure is used to quickly analyze the experimental result
and calculate approximate values for the dynamic parameters. A dedicat-
ed integrationmodule [44] is used to generate a surface tension response
based on these calculated dynamic parameters using Eq. (1). A curve
ﬁtting module [45] is responsible for comparing the calculated surface
tension values with the experimentally measured values, and modifying
theparameter values until amatched surface tension response is obtained
using a dedicated optimization procedure.
It is important to note that only one common value is used as the ini-
tial guess for both the elasticity of compression ( c) and the elasticity of
expansion ( e). Physically, both parameters would be the same if the
ﬁlm had the same composition during compression and expansion.
This point has been discussed in detail elsewhere [36].
3. Results
The dynamic cycling for a speciﬁc concentration is performed by
successive compression/expansion of the drop. This is normally done
through 20 cycles with the prescribed periodicity and the preselected
compression ratio (percentage of surface area reduction). In this
paper, 36 experiments are reported: 4 concentrations (2, 8, 15, or
27 mg/ml), 3 periodicities (1, 3, or 9 s per cycle), and 3 compression
ratios (10%, 20%, or 30%); each experimental run contains 20 cycles
and is repeated at least 3 times. In total, 108 runs were performed.
During every experimental run, images are acquired continuously at
a rate of 30 images per second (for periodicity of 1 s per cycle) or 20
images per second (for periodicities of 3 and 9 s per cycle). A typical
run contains approximately 600 images (20 cycles, 1 s per cycle and
30 images per second), 1200 images (20 cycles, 3 s per cycle and 20
images per second) or 3600 images (20 cycles, 9 s per cycle and 20
images per second). Thus, results reported here rely on almost
200,000 individual surface tension measurements, involving the analy-
sis of that number of drop images. These images are stored and later
analyzed with ADSA. For every image, ADSA calculates the surface
tension, the surface area, and the drop volume as shown in Fig. 2. The
reproducibility between cycles is apparent from Fig. 2.
The minimum value for surface tension for every cycle can be
obtained by inspection from the output of ADSA. A typical run includes
20 values for the minimum surface tension. The reported minimum
surface tension value is the average value within a particular run. For
a speciﬁc condition (concentration, compression ratio, and compression
rate), at least three runs were performed. From every run, an average
minimum surface tension is reported in Fig. 3.
Fig. 3 shows the average minimum surface tension, γmin, measured
for four different concentrations of BLES (2, 8, 15, 27 mg/ml) at differ-
ent compression ratios (10%, 20%, 30%) and different cycling condi-
tions (1, 3, 9 s/cycle). The standard deviation indicated by the error
bars shows good reproducibility between runs repeated under the
same conditions.At higher concentration, theminimum surface tension is sensitive to
changes in periodicity only at small compression ratios. At 10%
compression, theminimum surface tension decreases with the increase
of concentration and with the increase of cycling rate. For 20%
compression and above, the minimum surface tension decreases in
the range of 2 mg/ml to 8 mg/ml but stays essentially constant at higher
concentrations.
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change in minimum surface tension. In clinical practice, high concen-
tration BLES of 27 mg/ml is used [1,8]. and it is believed to be diluted
after delivery to the lungs to a concentration close to 8 mg/ml
[46,9,47–52].
Generally, increasing the extent of compression produces lower min-
imum surface tension values. This agrees with previous investigations of
BLES at 0.5 and 5 mg/ml and cycling speeds of 3 and 10 s per cycle [10].
At high concentrations, the speed of cycling does not have a signiﬁcant
effect on theminimum surface tension. The decrease ofminimum surface
tension with the increase of the speed of compression at low concentra-
tions agrees with previous investigations in the literature of BLES
0.5 mg/ml and 20% compression [10]. This dependence of minimum
surface tension on speed is probably due to the fact that the speed of
compression seems to be fast enough to prevent, in part, the hydration
of the surfactant ﬁlm [10].
It is important to note that ADSA–CSD studies can be performed
readily at high rates of compression (to mimic human breathing at
3 s per cycle). In this study, higher rates are also reported (up to 1 s
per cycle or 1 Hz). Even higher rates of compression are achievable
after hardware upgrades for both the liquid control and image acqui-
sition systems. It is noted that ﬂow conditions and bulk viscosity
might introduce errors in the measurement of surface tension via
drop/shape methods when the cycling frequencies are 10 Hz or larger
[53–55]. Therefore, an upper limit of 10 Hz exists for the high fre-
quency studies. Our experiments are well below this limit so that it
is safe to neglect the effect of bulk viscosity.
So far we have only considered the minimum surface tension value
obtained at different conditions. While this minimum value may well be
a useful indication of the response of that preparation to certain external
conditions such as concentration, compression rate and ratio, it does not
give a deeper understanding of the role neither of macroscopic effects
like ﬁlm elasticity nor microscopic or molecular effects such as effective
adsorption coefﬁcient of the ﬁlm forming molecular species. It is the pur-
pose of the Compression–Relaxation Model (CRM) to provide such
insight.
Using the output of ADSA for every experimental run, the change of
surface tension and surface area with time are analyzed using CRM fol-
lowing the procedure explained in Section 2.3. As mentioned earlier, a
typical experimental run consists of 20 cycles. From every cycle, the four
dynamic parameters of CRM are evaluated, i.e. elasticity of compression
( c), elasticity of expansion ( e), desorption/relaxation coefﬁcient (kr),
and adsorption coefﬁcient (ka). An indication of the goodness of ﬁt is
also calculated for every cycle. The goodness of ﬁt is deﬁned below in
Eq. (3), indicating the relative error between thepredicted surface tension
response from CRM and the experimentally measured surface tension
response. Smaller values for the goodness of ﬁt indicate a better ﬁt.
Figs. 4 and 5 show sample experimental results of the change in
surface tension with time and with relative surface area during
dynamic cycling. Fig. 4 shows results of BLES concentrations 2 and
27 mg/ml at 10% compression and periodicities of 1 and 9 s per
cycle. Fig. 5 shows corresponding results at 30% compression. The
ﬁgures illustrate the quality, or “goodness of ﬁt" of CRM to the
experimental data. In these ﬁgures, the symbols represent the mea-
sured experimental results and the continuous lines represent the
best-ﬁt CRM curves, the four parameters ( c, e, kr, and ka) determined
from the experimental points having been used for the calculation of
CRM curves.
Generally, results shown in Figs. 4 and 5 show that CRM ﬁts almost all
experimental conditions (high and low concentrations, cycling rates and
compression ratios) very well. It can be concluded that the model using
only four adjustable parameters is capable of capturing the features of
the dynamic cycling for different conditions. However, there is a slight in-
consistency between the model and the experimental results at the high
surface tension range in some cases, e.g. Fig. 5(b) and (d). This disagree-
ment only appears at the highest compression ratio (30%) and the lowestcompression rates (9 s per cycle). In these cases, the compression is slow,
and hence the details of the adsorption and elasticity effects are
pronounced near the highest surface tension values. As the area is in-
creased, the surface tension increases due to the ﬁlm elasticity; however,
if the surface tension exceeds the equilibrium value, the surface tension
tends to decrease at the same time due to adsorption to the interface.
Since the compression is slow in these cases, the surface tension shows
some ﬂuctuations near the highest surface tension range. The adsorption
in such cases is much quicker than the speed of compression, causing
these ﬂuctuations to be very pronounced. Such low compression rates
are not really relevant clinically; however, this lack of agreement is
considered in more detail below.
The same procedure of extracting the dynamic parameters from
every cycle is applied for all 20 cycles in every experimental run. An ef-
fective value for each of the parameters is formed by the multi-variable
optimization for every cycle. 20 values for each of the four dynamic
parameters and the goodness of ﬁt are calculated for every run. From
every run, average values are calculated. For a speciﬁc condition
(concentration, compression ratio, and compression rate), at least
three runs were performed. For each of the 36 different experimental
conditions considered, the values of the goodness of ﬁt and the four
dynamic parameters reported below in Figs. 6 to 10 are the average
values of the parameter plotted on the ordinate across repeated runs
and the 95% conﬁdence limit.
The visual judgment of a good ﬁt between experimental points and
calculated curves can be quantiﬁed by means of a “goodness of ﬁt". Fig. 6
compares the values of the goodness of ﬁt from CRM calculated at different
experimental conditions. The goodness of ﬁt is deﬁned as:
GF ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
∑ γe−γm
γe

2
s
ð3Þ
where γe is the experimentally measured surface tension value and γm
is the predicted surface tension value from CRM. Smaller values for the
goodness of ﬁt indicate a better ﬁt. It turns out that CRM ﬁts almost all
experimental conditions (high and low concentrations, cycling rates
and compression ratios) very well except for a few points at higher
compression ratios. The best results for the goodness of ﬁt are at any
concentration at low compression ratios and high frequency cycling.
These conditions are relevant to clinical practice of high frequency
ventilation. The goodness of ﬁt gives an indication of the conditions
where CRM works best. This point of the applicability of the model to
certain conditions is considered in more detail below.
Figs. 7 and 9 show the calculated elasticity of compression, c, and
elasticity of expansion, e, obtained at different experimental condi-
tions. Figs. 8 and 10 show the calculated relaxation coefﬁcient, kr,
and adsorption coefﬁcient, ka, obtained at different experimental
conditions. A detailed inspection of every parameter will follow
below. In these four ﬁgures, the values reported are the average
values across repeated runs and the 95% conﬁdence limit. Asterisks
are used in these ﬁgures to highlight points where CRM is less
sensitive to one or more of the parameters. The quantiﬁcation of the
sensitivity of the model is described in Section 4.2.
4. Discussion
4.1. Dynamic CRM parameters
The change of the elasticity of compression, c, with concentration,
compression ratio and compression rate is shown in Fig. 7. It is expected
that the elasticity is an intrinsic property of the lung surfactant prepara-
tion that should not change with different experimental conditions. The
elasticity of compression did indeed remain almost the same with
concentration beyond 8 mg/ml. There is also no signiﬁcant change with
compression ratio or compression rate. This agrees with previous studies
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Fig. 4. The change in surface tension with time and with relative surface area during dynamic cycling of BLES at 10% compression and different concentrations and periodicities:
(a) 2 mg/ml and 1 s/cycle; (b) 2 mg/ml and 9 s/cycle; (c) 27 mg/ml and 1 s/cycle; (d) 27 mg/ml and 9 s/cycle. Symbols show the measured surface tension values and lines
show the values predicted from CRM.
108 S.M.I. Saad et al. / Biochimica et Biophysica Acta 1818 (2012) 103–116on BLESwith concentrations 0.5 and 2 mg/ml at 20% compression and 3 s
per cycle [36]. In previous studies of DPPC spread ﬁlms at compression
ratios between 0.1 and 30% and frequencies 0.02, 0.05 and 0.1 Hz, the
dilatational elasticities were found to be almost constant for compression
ratios higher than 1% and for all frequencies studied [56]. Spread ﬁlms of
of n-dodecyl dimethyl phosphine oxide (DC12PO), at compression ratios
in the range of 2% to 10% and frequencies in the range of 0.015 to
0.57 Hz, did not show signiﬁcant change in the dilatational elasticities
[57].Elasticity of compression of BLES was previously evaluated using
an elementary procedure [10]. The surface tension–relative area
curve during the compression stage was ﬁtted to a fourth order poly-
nomial equation, and the ﬁrst derivative was used to calculate the di-
latational elasticity at the midpoint of the compression. Using this
elementary procedure with the current data of BLES 2 mg/ml, 20%
compression and 3 s/cycle produces values for the elasticity of com-
pression around 100 mJ/m2, while values calculated here are between
130 and 140 mJ/m2. Therefore, the elasticity of compression values are
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Fig. 5. The change in surface tension with time and with relative surface area during dynamic cycling of BLES at 30% compression and different concentrations and periodicities: (a)
2 mg/ml and 1 s/cycle; (b) 2 mg/ml and 9 s/cycle; (c) 27 mg/ml and 1 s/cycle; (d) 27 mg/ml and 9 s/cycle. Symbols show the measured surface tension values and lines show the
values predicted from CRM.
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used. The same effect exists for other experiments at different condi-
tions. The reason for this is the role of desorption: The elementary pro-
cedure assumes that the elasticity is the only active physical
phenomenon during the ﬁlm compression neglecting any effects of
desorption/relaxation. On the other hand, CRM accounts for simulta-
neous effects of elasticity and relaxation during the ﬁlm compression.
The relaxation causes an increase in the surface tension during com-
pression especially in humid conditions, and that increase becomeslarger as the ﬁlm is compressed as explained in Eq. (1b). Therefore,
neglecting relaxation causes the elasticity of compression to be
underestimated.
Other studies of DPPC/SP-B, DPPC/SP-C, DPPC/SP-B/SP-C spread
ﬁlms did not show any dependence of the elasticity on the compression
speed [58–60,35]. These results support the concept that more ﬂexible
ﬁlm structures are formed in the presence of surfactant proteins [61].
It can be concluded that the elasticity parameter in CRM is a property
of the lung surfactant preparation. In fact, the addition of an inhibitor,
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Fig. 6. The goodness of ﬁt for CRM measured for four different concentrations of BLES
(2, 8, 15, 27 mg/ml) at different compression ratios (10%, 20%, 30%) and different cycling
conditions (1, 3, 9 s/cycle). The error bars indicate the standard deviation between runs
repeated under the same conditions.
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110 S.M.I. Saad et al. / Biochimica et Biophysica Acta 1818 (2012) 103–116e.g. serum, albumin, ﬁbrinogen, or excess cholesterol, to lung surfactant
preparations is known to signiﬁcantly reduce the elasticity of compres-
sion of BLES [27].
The change of the relaxation coefﬁcient, kr, with concentration,
compression ratio and compression rate is shown in Fig. 8. There is
some variability but not a pronounced dependence on surfactant
concentration.There is no signiﬁcant dependence on concentrations at all compres-
sion ratios or compression rates except for a few points at the 10% com-
pression. There is a small increase in the relaxation coefﬁcient when the
compression ratio is increased from 20% to 30%. This agrees with pub-
lished results for BLES [10].
0 5 10 15 20 25 300
1
2
3
4
5
BLES Concentration (mg/ml)
k r
 
(s−
1 )
20% compression
0 5 10 15 20 25 300
1
2
3
4
5
BLES Concentration (mg/ml)
k r
 
(s−
1 )
30% compression
0 5 10 15 20 25 30
0
1
2
3
4
5
BLES Concentration (mg/ml)
k r
 
(s−
1 )
10% compression
1 s/cyc
3 s/cyc
9 s/cyc
**
**
**
**
a)
b)
c)
Fig. 8. The relaxation coefﬁcient, kr, calculated from CRM for four different concentra-
tions of BLES (2, 8, 15, 27 mg/ml) at different compression ratios (10%, 20%, 30%) and
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ity (explained in Fig. 12): * indicate points with range of insensitivity bigger than 0.2, **
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sion; the higher the frequency, the higher the relaxation coefﬁcient.
This agrees with other studies of BLES [10] and DC12PO [57].
It has to be kept inmind that themagnitude or extent of relaxation, i.e.
the increase of surface tension with time, decreases with the increase of
compression rate. This can be seen in Fig. 5. Fig. 5(a) shows the changeof surface tension with relative surface area at a high compression rate
(1 s/cycle) while Fig. 5(b) shows similar results at a lower compression
rate (9 s/cycle). It is clear that themagnitude of surface tension relaxation
is larger in the second case. The decrease in surface tension relaxation
with increasing compression rate is consistent with previous work [10]
and the trend expected from Hall's super-compression model [37]. The
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Fig. 10. The adsorption coefﬁcient, ka, calculated from CRM for four different concentra-
tions of BLES (2, 8, 15, 27 mg/ml) at different compression ratios (10%, 20%, 30%) and
different cycling conditions (1, 3, 9 s/cycle). The asterisks show the range of insensitiv-
ity (explained in Fig. 12): * indicate points with range of insensitivity bigger than 0.2, **
indicate points with range of insensitivity bigger than 0.5.
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relaxation coefﬁcient can be understood fromEq. (1b). For the same com-
pression rate, the increase or decrease of themagnitude of surface tension
relaxationwill correspond to a similar change in the relaxation coefﬁcient.
However, for different compression rates, the relationship between the
magnitude of surface tension relaxation and the relaxation coefﬁcientwill depend on the time available for relaxation; this time is generally
shorter for higher compression rates. In analyzing the trends of the relax-
ation coefﬁcients, it is also important to note that BLES does not have all
the surfactant proteins of the original bovine surfactant. BLES is deﬁcient
in SP-B whose role is to stabilize the surfactant ﬁlm [2]. Future studies
using CRM framework should be conducted to explore these effects in
more detail.
The change of the elasticity of expansion, e, with concentration, com-
pression ratio and compression rate is shown in Fig. 9. Values are very
close to the elasticity of compression. Generally, there is no signiﬁcant
dependence on concentration, compression ratio or compression rate.
However, the sensitivity of themodel to changes in eofmost experiments
at 30% compression is low. This leads to less reliable values at these
conditions.
The change of the adsorption coefﬁcient, ka, with concentration,
compression ratio and compression rate is shown in Fig. 10. There is
some variability but not a pronounced dependence on surfactant
concentration. However, this variability is reproducible as indicated by
the error bars in the ﬁgure. The adsorption coefﬁcient seems to increase
with the increase of the compression ratio and compression rate.
However, the sensitivity of most points at 20% and 30% compression is
very low. This leads to less reliable ka values at these conditions. More
details regarding the sensitivity of the model are given in Section 4.2.
4.2. Sensitivity of CRM
For some experiments reported here, it is noticed that the ﬁtting of
CRM to the experimental results are not sensitive to one ormore of the
four dynamic parameters. To further investigate this point, a detailed
sensitivity study was performed. The details of calculating the “range
of insensitivity” for each parameter is given in Appendix A. Brieﬂy, it
is attempted to identify for each parameter the range in which CRM
is not highly sensitive. The sensitivity of the model (in terms of the
goodness of ﬁt) to changes in the respective parameter is calculated
as the percentage change of the goodness of ﬁt divided by the percent-
age change of the parameter. For example, a sensitivity of 1means that
a relative change of, say 20%, of a speciﬁc parameter yields a relative
change of the same amount, 20% in this case, of the goodness of ﬁt.
A sensitivity cut-off level of 1 is chosen to differentiate between sensi-
tive and insensitive values. The range of percentage change of the pa-
rameter in which the sensitivity of the model is below 1 is called here
the “range of insensitivity” for a speciﬁc parameter. The procedure is
applied for each of the four parameters of CRM and the range of insen-
sitivity is calculated for each in all experiments. A summary of these
calculations is shown in Fig. 11.
In this ﬁgure, the contour lines show the range of insensitivity for
each parameter. Higher values indicate that themodel is less sensitive
to a wider range for this speciﬁc parameter. It can be seen that there
are similarities between the insensitivity contours of both elasticity of
compression and relaxation coefﬁcient and also between both elastic-
ity of expansion and adsorption coefﬁcient.
From these contours, experimental conditions can be identiﬁedwhere
CRM is less sensitive to certain parameters. Such information can be very
useful as recommendations canbemade towhat experimental conditions
are to be used if there is an interest in a speciﬁc parameter. For example,
the elasticity of compression, c, and the relaxation coefﬁcient, kr, are less
sensitive at high concentrations, high compression ratios, and high
cycling rates. The ﬁt is also less sensitive to c and kr at low compression
ratios and low cycling rates; at these conditions the parameters e and ka
are more sensitive. The elasticity of expansion, e, and the adsorption
coefﬁcient, ka, are less sensitive at high concentrations and high
compression ratios.
It is important to note that CRM is generally sensitive to all the param-
eters at any concentration at physiological conditions of 20% compression
and 3 seconds per cycle. The model is also sensitive to all the parameters
at any concentration at low compression ratios and high frequency
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Fig. 11. Contour lines of the range of insensitivity for each of the parameters: (a) c, (b) e, (c) kr, (d) ka, at different periodicities, compression ratios and concentrations. The cal-
culation of the range of insensitivity is explained in Fig. 12.
113S.M.I. Saad et al. / Biochimica et Biophysica Acta 1818 (2012) 103–116cycling. These conditions are relevant to conventional and high frequency
ventilation.
Generally, the effect of the concentration on the four dynamic
parameters is minimal beyond 8 mg/ml. We infer that such lung surfac-
tant studies should generally be performed at concentrations if 8 mg/ml
or higher, to guarantee clinical relevance. This is important for clinical
therapeutic practice where it is believed that increased concentration
will improve the surfactant properties. As shown here, increasingsurfactant concentration does improve the dynamic properties only in
the low concentration range below 8 mg/ml.
Although the dynamic properties of BLES-only preparations do not im-
prove signiﬁcantly with increasing BLES concentration, the samemight not
be true in the presence of inhibitors. For example, it was shown before [36]
that when albumin is added to BLES, the elasticity value is markedly de-
creased indicating surfactant inactivation or inhibition. Using ADSA–CSD
in combination with CRM, the effect of relevant additives and/or inhibitors
114 S.M.I. Saad et al. / Biochimica et Biophysica Acta 1818 (2012) 103–116could be evaluated at appropriate conditions of concentration, compression
rate and compression ratio.
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Appendix A. Range of insensitivity
This appendix explains the calculations of the range of insensitiv-
ity for each parameter of CRM. First, the change of goodness of ﬁt (de-
ﬁned in Eq. (3)) is recalculated after changing the respective
parameter around the calculated value while keeping the rest of the
parameters constant. Two examples are shown in Fig. 12(a) and (b)
for one of the cycles of 2.0 mg/ml BLES at 20% compression ratio
with a periodicity of 9 s per cycle. In Fig. 12(a), the change of good-
ness of ﬁt is plotted versus the change of one of the parameters ( c)
around the calculated value while keeping the rest of the parameters
( e, kr, ka) constant. In Fig. 12(b), the change of goodness of ﬁt is plot-
ted versus the change of one of the parameters (ka) around the0 20 40 60 80 100 120 140 160 180 2000
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change of goodness of ﬁt with the change of ka around the calculated value while keeping the
relative change of c. (d) The relative change of sensitivity with the relative change of ka. The
sensitivity is below 1.calculated value while keeping the rest of the parameters ( c, e, kr)
constant.
The second step is to calculate the sensitivity of the model (in
terms of the goodness of ﬁt) to changes in the respective parameter
by calculating the percentage change of the goodness of ﬁt divided
by the percentage change of the parameter. For example, for the
case of the adsorption coefﬁcient, ka, the sensitivity of the model
with respect to this parameter is,
S ¼ ΔGF=GF
Δka=ka

 ðA:1Þ
Samples are shown in Fig. 12(c) and (d) for the same experiment.
In these ﬁgure, the relative change of sensitivity is plotted versus the
relative change of one of the parameters ( c or ka).
The third step is to deﬁne the “range of insensitivity” based on the
sensitivity calculations. A cut-off level of 1 is chosen to differentiate
between sensitive and insensitive values. If the change in the respec-
tive parameter yields a sensitivity more than 1, the model is consid-
ered sensitive to this parameter at this change level, and vice versa.
Hence, the range of insensitivity for this parameter is deﬁned as the
range of percentage change of the parameter in which the sensitivity
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adsorption coefﬁcient ka of one cycle for 2.0 mg/ml BLES at 20% compression ratio with
e calculated value while keeping the rest of the parameters ( e, kr, ka) constant. (b) The
rest of the parameters ( c, e, kr) constant. (c) The relative change of sensitivity with the
range of insensitivity is the range of percentage change of the parameter in which the
115S.M.I. Saad et al. / Biochimica et Biophysica Acta 1818 (2012) 103–116In our example of Fig. 12(c), CRM is found to be insensitive to small
changes in this parameter, c, in the range of roughly 98% to 102% of the
calculated value for c. This means that the range of insensitivity of the
model to the parameter c is found to be 0.04 in this experiment as
shown in the ﬁgure. In Fig. 12(d), CRM is found to be insensitive to
small changes in this parameter, ka, in the range of roughly 82% to
133% of the calculated value for ka. This means that the range of insen-
sitivity of themodel to the parameter ka is found to be 0.51 in this exper-
iment as shown in the ﬁgure.
The same procedure is applied for each of the four parameters of
CRM and the range of insensitivity is calculated for each in all the
experiments. A summary of these calculations is shown in Fig. 11.References
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